Indian Company Master Data Made Simple
Kabra Drugs Limited
Profile data last updated: 20/12/2024
Kabra Drugs Limited has been active since 1989, providing more than 36 years of industry experience. Corporate ID: L02423MP1989PLC005438, registered with number 5438. The firm is categorized as company limited by shares. The declared authorized capital is ₹20.00 crore. Paid-up capital currently stands at ₹10.08 crore.
The firm focuses on forestry, logging and related service activities. The company’s registration location is Gwalior. The company is incorporated with the address 208 Swadesh Bhavan, 2 Press Complex, Ab Road, Indore R.s.s.nagar, Indore, Indore, Madhya Pradesh, India, 452011. The firm continues to be in active status. Kabra Drugs Limited can be contacted at [email protected]. At the helm are Bangalore Venkatakrishnappa Ananth Kumar (CFO).
Company Overview
- CIN
- Date of Incorporation
- 22/08/1989
- Company Status
- Active
- RoC
- Gwalior
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹20,00,00,000.00
- Paid up Capital
- ₹10,07,91,000.00
- Activity
- FORESTRY, LOGGING AND RELATED SERVICE ACTIVITIES
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹0.04L | -₹0.01L | ₹0.00L | ₹0.00L | ₹0.00L |
| Accumulated Depreciation | -₹0.73L | -₹16.63L | -₹16.63L | -₹16.63L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹57.43L | ₹348.86L | ₹143.46L | ₹112.28L | ₹0.00L |
| Tangible Book Value | ₹2,465.47L | ₹108.29L | -₹73.10L | -₹39.31L | ₹0.00L |
| Long Term Debt | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹43.74L | ₹170.85L | ₹138.19L | ₹102.58L | ₹0.00L |
| Machinery Furniture Equipment | ₹4.51L | ₹16.63L | ₹16.63L | ₹16.63L | ₹0.00L |
| Total Assets | ₹2,522.90L | ₹457.15L | ₹70.36L | ₹72.97L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹2,465.47L | ₹108.29L | -₹73.10L | -₹39.31L | ₹0.00L |
| Gross PPE | ₹5.12L | ₹16.63L | ₹16.63L | ₹16.63L | ₹0.00L |
| Common Stock | ₹2,370.79L | ₹438.86L | ₹438.86L | ₹438.86L | ₹0.00L |
| Total Capitalization | ₹2,465.47L | ₹108.29L | -₹73.10L | -₹39.31L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Debt | ₹43.74L | ₹170.85L | ₹138.19L | ₹102.58L | ₹0.00L |
| Other Equity Interest | ₹94.68L | ₹255.00L | ₹0.00L | -₹478.17L | -₹459.63L |
| Other Non Current Liabilities | -₹0.01L | -₹0.01L | ₹0.00L | ₹0.00L | ₹0.00L |
| Capital Stock | ₹2,370.79L | ₹438.86L | ₹438.86L | ₹438.86L | ₹0.00L |
| Additional Paid In Capital | ₹788.82L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Non Current Assets | ₹6.71L | ₹2.32L | ₹2.32L | ₹2.32L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹2,129.92L | ₹267.10L | ₹0.29L | ₹0.13L | ₹0.00L |
| Invested Capital | ₹2,509.21L | ₹279.14L | ₹65.09L | ₹63.26L | ₹0.00L |
| Net Tangible Assets | ₹2,465.47L | ₹108.29L | -₹73.10L | -₹39.31L | ₹0.00L |
| Cash And Cash Equivalents | ₹2,129.92L | ₹267.10L | ₹0.29L | ₹0.13L | ₹0.00L |
| Prepaid Assets | ₹326.22L | ₹127.70L | ₹7.70L | ₹10.48L | ₹0.00L |
| Stockholders Equity | ₹2,465.47L | ₹108.29L | -₹73.10L | -₹39.31L | ₹0.00L |
| Other Short Term Investments | ₹4.36L | ₹375.44L | ₹0.00L | ₹0.09L | ₹0.08L |
| Share Issued | ₹237.08L | ₹43.89L | ₹43.89L | ₹43.89L | ₹0.00L |
| Current Assets | ₹2,516.19L | ₹454.84L | ₹68.04L | ₹70.65L | ₹0.00L |
| Working Capital | ₹2,458.80L | ₹105.97L | -₹75.42L | -₹41.63L | ₹0.00L |
| Ordinary Shares Number | ₹237.08L | ₹43.89L | ₹43.89L | ₹43.89L | ₹0.00L |
| Current Debt | ₹43.74L | ₹170.85L | ₹138.19L | ₹102.58L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Liabilities | ₹57.39L | ₹348.87L | ₹143.46L | ₹112.28L | ₹0.00L |
| Retained Earnings | -₹694.14L | -₹585.57L | -₹511.96L | -₹478.17L | ₹0.00L |
| Net PPE | ₹4.39L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Common Stock Equity | ₹2,465.47L | ₹108.29L | -₹73.10L | -₹39.31L | ₹0.00L |
| Other Non Current Assets | ₹2.32L | ₹2.32L | ₹0.00L | ₹2.32L | ₹2.32L |
| Inventory | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Properties | ₹0.61L | ₹0.00L | ₹0.00L | ₹0.00L | ₹1.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Changes In Cash | ₹1,862.82L | ₹266.81L | ₹0.17L | -₹0.85L | ₹0.00L |
| Financing Cash Flow | ₹2,338.63L | ₹287.66L | ₹35.61L | ₹12.53L | ₹0.00L |
| Investing Cash Flow | -₹5.13L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Free Cash Flow | -₹475.81L | -₹20.85L | -₹35.44L | -₹13.38L | ₹0.00L |
| End Cash Position | ₹2,129.93L | ₹267.10L | ₹0.29L | ₹0.13L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | ₹0.01L | ₹0.00L | ₹0.00L | ₹0.00L | -₹0.00L |
| Capital Expenditure | -₹5.13L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Beginning Cash Position | ₹267.10L | ₹0.29L | ₹0.13L | ₹0.98L | ₹0.00L |
| Operating Cash Flow | -₹470.68L | -₹20.85L | -₹35.44L | -₹13.38L | ₹0.00L |
| Issuance Of Capital Stock | ₹2,465.74L | ₹255.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Rent Expense Supplemental | ₹4.54L | ₹3.56L | ₹2.34L | ₹2.35L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | -₹108.56L | -₹73.61L | -₹33.79L | -₹18.54L | ₹0.00L |
| Basic EPS | -₹0.00L | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| EBITDA | -₹107.78L | -₹73.61L | -₹33.79L | -₹17.54L | ₹0.00L |
| Total Expenses | ₹172.42L | ₹73.56L | ₹34.40L | ₹18.53L | ₹0.00L |
| Total Unusual Items | ₹64.02L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Revenue | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹19.21L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹64.02L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | -₹108.56L | -₹73.61L | -₹33.79L | -₹18.54L | ₹0.00L |
| General And Administrative Expense | ₹14.58L | ₹2.54L | ₹4.67L | ₹0.80L | ₹0.00L |
| Reconciled Depreciation | ₹0.73L | ₹0.00L | ₹0.00L | ₹1.00L | ₹0.00L |
| Net Income Continuous Operations | -₹108.56L | -₹73.61L | -₹33.79L | -₹18.54L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | -₹108.56L | -₹73.61L | -₹33.79L | -₹18.54L | ₹0.00L |
| Operating Income | -₹172.42L | -₹73.56L | -₹34.40L | -₹18.53L | ₹0.00L |
| Diluted Average Shares | ₹109.28L | ₹43.89L | ₹43.89L | ₹43.89L | ₹0.00L |
| Selling And Marketing Expense | ₹1.69L | ₹1.86L | ₹0.87L | ₹0.69L | ₹0.00L |
| Normalized Income | -₹153.37L | -₹73.61L | -₹33.79L | -₹18.54L | ₹0.00L |
| Total Other Finance Cost | ₹0.10L | ₹0.05L | ₹0.03L | ₹0.01L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹0.10L | -₹0.05L | ₹0.61L | -₹0.01L | ₹0.00L |
| EBIT | -₹108.51L | -₹73.61L | -₹33.79L | -₹18.54L | ₹0.00L |
| Gross Profit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cost Of Revenue | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | -₹108.56L | -₹73.61L | -₹33.79L | -₹18.54L | ₹0.00L |
| Net Interest Income | -₹0.10L | -₹0.05L | ₹0.61L | -₹0.01L | ₹0.00L |
| Operating Expense | ₹172.42L | ₹73.56L | ₹34.40L | ₹18.53L | ₹0.00L |
| Normalized EBITDA | -₹171.80L | -₹73.61L | -₹33.79L | -₹17.54L | ₹0.00L |
| Net Income Common Stockholders | -₹108.56L | -₹73.61L | -₹33.79L | -₹18.54L | ₹0.00L |
| Pretax Income | -₹108.51L | -₹73.61L | -₹33.79L | -₹18.54L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Selling General And Administration | ₹16.27L | ₹4.40L | ₹5.54L | ₹1.49L | ₹0.00L |
| Total Revenue | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Operating Expenses | ₹81.65L | ₹25.56L | ₹3.36L | ₹4.76L | ₹0.00L |
| Diluted EPS | -₹0.00L | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| Interest Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic Average Shares | ₹109.28L | ₹43.89L | ₹43.89L | ₹43.89L | ₹0.00L |
| Net Income Including Noncontrolling Interests | -₹108.56L | -₹73.61L | -₹33.79L | -₹18.54L | ₹0.00L |
| Tax Provision | ₹0.05L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 29/01/2020 | Bangalore Venkatakrishnappa Ananth Kumar | 08644948 | Whole-time director | View other directorships |
| 29/01/2020 | Bangalore Venkatakrishnappa Ananth Kumar | *****0551M | CFO | |
| 19/02/2020 | Ananthkumar Shilpa | 08677992 | Director | View other directorships |
| 09/06/2022 | Kuniamuthur Nanjappan Anand | 03230186 | Director | View other directorships |
| 14/07/2022 | Anand Anitha | 02040505 | Director | View other directorships |
| 14/07/2022 | Monika Nishant Gattani | *****0301N | Company Secretary | |
| 14/08/2024 | Nanjappan Aravind | 01895602 | Additional Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 29/11/2024 | Form MGT-7-29112024 | - |
| 12/11/2024 | Form AOC-4(XBRL)-29102024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Beryl Drugs Limited | L02423MP1993PLC007840 | 133 Kanchan Bagh, Indore, Indore, Madhya Pradesh, India, 452001 |
| Bonanza Biotech Limited | L02423MP1981PLC001779 | 203, Apolo Tower, 2, M.g. Road, Indore, Madhya Pradesh, India, 000000 |
Address
208 Swadesh Bhavan, 2 Press Complex, Ab Road, Indore R.s.s.nagar, Indore, Indore, Madhya Pradesh, India, 452011
Frequently Asked Questions
What is the incorporation date of Kabra Drugs Limited?
The incorporation date of Kabra Drugs Limited is 22/08/1989.
What is the authorized share capital and paid-up capital of Kabra Drugs Limited?
The authorized share capital of Kabra Drugs Limited is ₹20,00,00,000.00. The paid-up capital is ₹10,07,91,000.00.
Who are the current board members & directors of Kabra Drugs Limited?
The current board member of Kabra Drugs Limited are:
- Ananthkumar Shilpa
- Kuniamuthur Nanjappan Anand
- Bangalore Venkatakrishnappa Ananth Kumar
- Anand Anitha
- Nanjappan Aravind
What is the registered address of Kabra Drugs Limited?
The registered address of Kabra Drugs Limited is 208 Swadesh Bhavan, 2 Press Complex, Ab Road, Indore R.s.s.nagar, Indore, Indore, Madhya Pradesh, India, 452011.
What is the Corporate Identification Number of Kabra Drugs Limited?
The Corporate Identification Number of Kabra Drugs Limited is L02423MP1989PLC005438.